Riskpilot← Back to searchSign inGet full accessXL Vet AB
ABActiveOrg 5567437800Minkvägen 1Veterinary activities · NACE 7500Est. 20070 employees
Revenue 2024
SEK 5,5M
-13% vs 2023
EBITDA margin
9.0%
-55% vs 2023
Equity ratio
75.1%
Financial strength
Net profit 2024
SEK 1,6M
+115% vs 2023
| Revenue | SEK 5,5M | -13% |
| EBITDA | SEK 495K | -55% |
| Net profit | SEK 1,6M | +115% |
| Total assets | SEK 5,2M | -11% |
| Equity | SEK 3,9M | -8% |
| Employees | 0 | — |
Legal name
XL Vet AB
Org number
5567437800
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
22 november 2007
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva veterinärverksamhet samt fastighetsförvaltning och därmed förenlig verksamhet.
Address
Minkvägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 218 | 5 712 | 6 200 | 6 322 | 5 513 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 782 | 1 120 | 1 025 | 1 099 | 495 |
| Depreciation & amort. | −139 | −148 | −153 | −148 | −103 |
| EBIT | 643 | 972 | 872 | 951 | 392 |
| Net financials | −1 | — | 98 | 12 | 1 335 |
| Profit before tax | 642 | 972 | 970 | 964 | 1 727 |
| Tax | −144 | −206 | −180 | −204 | −91 |
| Net profit | 498 | 766 | 790 | 760 | 1 636 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 561 | 5 004 | 5 236 | 5 868 | 5 248 |
| Equity | 3 419 | 4 007 | 4 197 | 4 307 | 3 943 |
| Long-term debt | 641 | 523 | 454 | 1 007 | 650 |
| Short-term debt | 501 | 474 | 584 | 554 | 655 |
| Total debt | 1 142 | 997 | 1 038 | 1 561 | 1 305 |
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
20202024
Equity ratio
75.1%
This company
38.2%
Market median
+97% vs market
20202024
Return on equity
41.5%
This company
18.4%
Market median
+126% vs market
20202024
Net profit margin
29.7%
This company
8.1%
Market median
+267% vs market
20202024
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20202024
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JG | Audit | 2022 |
EI Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of XL Vet AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Göran Gunnar Klingström | Audit | 0 companies |
| Elna Ingrid Susanne Eksell | Chief Executive Officer | 0 companies |
| Per Eksell | Board of Directors | 0 companies |